Related references
Note: Only part of the references are listed.Clinical experience with tigecycline in the treatment of hospital-acquired pneumonia caused by multidrug resistant Acinetobacter baumannii
Yangang Zhou et al.
BMC PHARMACOLOGY & TOXICOLOGY (2019)
The combined use of tigecycline with high-dose colistin might not be associated with higher survival in critically ill patients with bacteraemia due to carbapenem-resistant Acinetobacter baumannii
T. Amat et al.
CLINICAL MICROBIOLOGY AND INFECTION (2018)
A bovine myeloid antimicrobial peptide (BMAP-28) and its analogs kill pan-drug-resistant Acinetobacter baumannii by interacting with outer membrane protein A (OmpA)
Yijie Guo et al.
MEDICINE (2018)
Risk factors associated with multi-drug-resistant Acinetobacter baumannii nosocomial infections at a tertiary care hospital in Makkah, Saudi Arabia-a matched case-control study
Manal M. Al-Gethamy et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2017)
Small protein A and phospholipase D immunization serves a protective role in a mouse pneumonia model of Acinetobacter baumannii infection
Haitao Li et al.
MOLECULAR MEDICINE REPORTS (2017)
The efficacy and safety of tigecycline for the treatment of bloodstream infections: a systematic review and meta-analysis
Jian Wang et al.
ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS (2017)
Secular trends in Acinetobacter baumannii resistance in respiratory and blood stream specimens in the United States, 2003 to 2012: A survey study
Marya D. Zilberberg et al.
JOURNAL OF HOSPITAL MEDICINE (2016)
Resistance trends among clinical isolates in China reported from CHINET surveillance of bacterial resistance, 2005-2014
F-P. Hu et al.
CLINICAL MICROBIOLOGY AND INFECTION (2016)
Detection of the plasmid-mediated quinolone resistance determinants in clinical isolates of Acinetobacter baumannii in China
Haifei Yang et al.
JOURNAL OF CHEMOTHERAPY (2016)
Comparable Efficacy of Tigecycline versus Colistin Therapy for Multidrug-Resistant and Extensively Drug-Resistant Acinetobacter baumannii Pneumonia in Critically Ill Patients
Won-Young Kim et al.
PLOS ONE (2016)
Colistin-Resistant Acinetobacter baumannii: Beyond Carbapenem Resistance
Zubair A. Qureshi et al.
CLINICAL INFECTIOUS DISEASES (2015)
Emerging broad-spectrum resistance in Pseudomonas aeruginosa and Acinetobacter baumannii: Mechanisms and epidemiology
Anais Potron et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2015)
Acinetobacter baumannii: evolution of a global pathogen
Luisa C. S. Antunes et al.
PATHOGENS AND DISEASE (2014)
High dose tigecycline in critically ill patients with severe infections due to multidrug-resistant bacteria
Gennaro De Pascale et al.
CRITICAL CARE (2014)
Excess Deaths Associated With Tigecycline After Approval Based on Noninferiority Trials
Paritosh Prasad et al.
CLINICAL INFECTIOUS DISEASES (2012)
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
A. -P. Magiorakos et al.
CLINICAL MICROBIOLOGY AND INFECTION (2012)
Clinical Experience of Tigecycline Treatment in Infections Caused by Extensively Drug-Resistant Acinetobacter spp.
Soo-Youn Moon et al.
MICROBIAL DRUG RESISTANCE (2012)
Clinical Outcomes of Tigecycline in the Treatment of Multidrug-Resistant Acinetobacter baumannii Infection
Jung Ar Shin et al.
YONSEI MEDICAL JOURNAL (2012)
Treatment of Acinetobacter Infections
Joel Fishbain et al.
CLINICAL INFECTIOUS DISEASES (2010)
Multidrug Resistant Acinetobacter
Vikas Manchanda et al.
JOURNAL OF GLOBAL INFECTIOUS DISEASES (2010)
The Clinical Importance of Microbiological Findings in the Diagnosis and Management of Bloodstream Infections
Harald Seifert
CLINICAL INFECTIOUS DISEASES (2009)
CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting
Teresa C. Horan et al.
AMERICAN JOURNAL OF INFECTION CONTROL (2008)
Tigecycline for the treatment of multidrug-resistant (including carbapenem-resistant) Acinetobacter infections:: a review of the scientific evidence
Drosos E. Karageorgopoulos et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Optimal management therapy for Pseudomonas aeruginosa ventilator-associated pneumonia:: An observational, multicenter study comparing monotherapy with combination antibiotic therapy
Jose Garnacho-Montero et al.
CRITICAL CARE MEDICINE (2007)
The diversity of definitions of multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa
Matthew E. Falagas et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2006)
Comparative in vitro activities of tigecycline and 11 other antimicrobial agents against 215 epidemiologically defined multidrug-resistant Acinetobacter baumannii isolates
Harald Seifert et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Tigecycline: A glycylcycline antimicrobial agent
Thien-Ly Doan et al.
CLINICAL THERAPEUTICS (2006)
Prevention and control of antimicrobial-resistant infections in intensive care patients
CD Salgado et al.
CRITICAL CARE MEDICINE (2005)
The epidemiology of sepsis in the United States from 1979 through 2000
GS Martin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Share Paper
